Parents may feel overwhelmed to learn their child has a chronic illness such as asthma. Chronic means long-term, but not severe or unmanageable. According to Dr Will Carroll, a consultant respiratory paediatrician in the UK, parents have a vital role in helping children manage their asthma correctly.
Children's asthma is often poorly controlled because symptoms are wrongly tolerated as a 'fact of life', says Dr Will Carroll, a consultant respiratory paediatrician and a clinical and academic lead in paediatric respiratory medicine at University Hospitals of the North Midlands in the UK.
But not managing asthma correctly can have serious consequences, including life-threatening asthma attacks. Dr Carroll says it's vital parents are alert for any signs asthma may be causing problems – by talking, listening and watching their child.
“Alertness is awareness of what symptoms suggest that asthma is controlled or not,” explains Dr Carroll. “Do they need to use their blue inhaler (their reliever)? If the answer's more than twice a week, then the asthma is not well-controlled.”
Other signs Dr Carroll highlights include the child waking in the night, their sports or play being affected, or child needing a course of oral steroids to treat their asthma. To help keep an eye on this, Dr Carroll suggests asking questions and listening carefully to the answers.
“The first thing you have to do is ask the child,” he explains. “Parents assume if they've not been told by school, or they've not seen it, that it's not happening. But when you do ask them, lots of children are having symptoms. So make sure you're asking about things that are really important to the child, such as 'is your asthma stopping you from doing anything you want to do?’”
Taking medication properly is fundamental, says Dr Carroll. Some parents may become lax about this over time, thinking that their child may be 'outgrowing' their asthma – a common myth. Instead, it is the medication that is actually keeping everything under control.
Dr Carroll recommends parents watch their child use the inhaler, to ensure it's done at the right times and done properly. “Once a child is five or six and can put their mouth around a mouthpiece, it's about technique and memory,” he explains. “It's a complicated task to take most inhaler medications, and to assume that six-, seven-, eight-year-olds can do this unsupervised is a big mistake.”
It is also a good idea for children to use a spacer. Of course, they may not want to because it's uncool or inconvenient, but Dr Carroll points out that children may lack the coordination and inspiratory flow to use a dry powder device directly. Apps and online videos can help with inhaler technique.
According to Dr Carroll, most children tend to take over responsibility for their own medication at about age 13. While supervising your teen may not be as easy as it once was, parents can still play an important role to support their children with their condition.
“Teenagers are hard enough to deal with, so the parents' approach needs to change,” says Dr Carroll. 'We go back to talk, listen and watch – ensuring that they have enough medicines available, being vigilant, and then talking to them about it in a supportive way.”
As Dr Carroll concludes: “Giving time and space to allow the child to talk about their asthma is the critical message.”
By Esther Beadle
Photos and video by Dan Douglas
Wildhaber, Johannes & Carroll, William & Brand, Petrus. (2012). Global impact of asthma on children and adolescents' daily lives: the Room to Breathe Survey. Pediatric pulmonology.
47. 346-57. 10.1002/ppul.21557
Global impact of asthma on children and adolescents' daily lives the Room to Breathe Survey
Tags: asthma, children, asthma medication, corticosteroids, correct use of inhaler, parenthood and asthma
Date of preparation: September 2020 / RESP-330abd
|If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard|
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being for more than 100 years. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. Respiratory diseases are one of Orion’s core therapy areas. Orion's net sales in 2018 amounted to EUR 977 million and the company had about 3,200 employees. Orion's A and B shares are listed on Nasdaq Helsinki.® ®
As a forward-looking pharmaceutical company, Orion continues to invest in research and development of treatment options for people with asthma and COPD. The focus is on safety and quality in each step of the product life cycle while taking care of the environment. Sustainability is entwined in the whole process from R&D through manufacturing. It is also required of Orion’s providers. Orion is committed to keeping the best possible control of the environmental impacts of their own factories by reducing energy consumption and the impact of their waste waters, among others, and is making good progress in that regard. Orion works to ensure that suppliers have procedures in place to control and reduce their own environmental impacts as well. All aspects of sustainability - social, economic and environmental - are carefully considered in the whole product life cycle, including patient use and the disposal of old inhalers.